Alumis Ownership | Who Owns Alumis?
Alumis Ownership Summary
Alumis is owned by 102.40% institutional investors, 0.83% insiders. Foresite capital management v is the largest institutional shareholder, holding 7.56% of ALMS shares.
ALMS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Alumis | 102.40% | 0.83% | -3.22% |
Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Foresite capital management v | 5.78M | 7.56% | $17.34M |
Samsara biocapital | 4.80M | 6.28% | $14.40M |
Venbio partners | 4.62M | 6.04% | $13.86M |
Foresite capital management vi | 4.25M | 5.55% | $12.74M |
Blackrock funding, inc. /de | 4.18M | 5.46% | $12.53M |
Trium capital llp | 2.65M | 3.46% | $7.94M |
Cormorant asset management, lp | 2.15M | 2.81% | $6.44M |
Tang capital management | 2.00M | 2.61% | $5.99M |
Orbimed advisors | 1.93M | 2.52% | $5.78M |
Baker bros. advisors lp | 1.56M | 2.04% | $4.69M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Foresite capital management v | 5.78M | 21.48% | $17.34M |
Tybourne capital management (hk) | 1.40M | 12.15% | $4.20M |
Venbio partners | 4.62M | 12.08% | $13.86M |
Foresite capital management vi | 4.25M | 7.16% | $12.74M |
Samsara biocapital | 4.80M | 2.95% | $14.40M |
Bml capital management | 1.21M | 2.75% | $3.63M |
Trium capital llp | 2.65M | 1.98% | $7.94M |
Omega fund management | 653.22K | 1.27% | $1.96M |
Stonepine capital management | 349.62K | 1.03% | $1.05M |
Cormorant asset management, lp | 2.15M | 0.48% | $6.44M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock funding, inc. /de | 4.18M | 0.00% | 2.72M |
Trium capital llp | 2.65M | 1.98% | 2.65M |
Tang capital management | 2.00M | 0.30% | 2.00M |
Orbimed advisors | 1.93M | 0.14% | 1.93M |
Venbio partners | 4.62M | 12.08% | 1.83M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ally bridge group (ny) | - | - | -445.26K |
Sphera funds management | - | - | -125.00K |
Squarepoint ops | - | - | -24.15K |
Marshall wace, llp | - | - | -19.00K |
Xtx topco | - | - | -18.37K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Trium capital llp | 2.65M | 1.98% | 2.65M | $7.94M |
Orbimed advisors | 1.93M | 0.14% | 1.93M | $5.78M |
Tybourne capital management (hk) | 1.40M | 12.15% | 1.40M | $4.20M |
General atlantic | 1.30M | 0.11% | 1.30M | $3.89M |
Cantor fitzgerald, l. p. | 559.20K | 0.03% | 559.20K | $1.68M |
Sold Out
Holder | Change |
---|---|
True wealth design | -4.00 |
Gamma investing | -19.00 |
Rothschild investment | -25.00 |
Comerica bank | -104.00 |
Massmutual trust co fsb/adv | -144.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 121 | 68.06% | 78,309,349 | 94.78% | 102 | 1.87% | 102 | 104.00% | 2 | -50.00% |
Mar 31, 2025 | 71 | 14.52% | 40,200,845 | 0.23% | 74 | 1.33% | 49 | 25.64% | 4 | -33.33% |
Dec 31, 2024 | 63 | 23.53% | 40,259,042 | 15.07% | 74 | 1.77% | 40 | - | 6 | 50.00% |
Sep 30, 2024 | 51 | 75.86% | 34,986,402 | 22.44% | 65 | 2.36% | 40 | 37.93% | 4 | - |
Jun 30, 2024 | 29 | - | 28,575,030 | - | 52 | - | 29 | - | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 02, 2025 | Tananbaum James B. | Buy | $115.50K | |
May 06, 2025 | Tananbaum James B. | Buy | $86.80K | |
May 02, 2025 | Foresite Labs, LLC | - | Buy | $115.50K |
May 06, 2025 | Foresite Labs, LLC | - | Buy | $86.80K |
May 06, 2025 | Foresite Capital Management VI LLC | - | Buy | $86.80K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | 12 | - |
ALMS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools